RESPIRATORY Flashcards

1
Q

GOAL OF FEV1

A

> / 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

goal of using reliever therapy

A

<2/wk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when should LABA be used in asthma

A

only if patient is already taking ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List the ICS inhaler

A
beclomethasone 
budesonide,
 ciclesonide, 
fluticasone furoate, fluticasone propionate 
and mometasone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

which drug are LABA

which has slow and rapid acting

A

salmeterol, formoterol, indacaterol, vilanterol

**formoterol is rapid acting, the rest is short acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

can budesonide/formoterol be used as rescue? what about salmeterol/ICS?

A

formoterol/ budesonide can be used as rescue as it is rapid acting,
salmeterol/ ICS is not

** note budesonide/formoterol can be use as rescue and controller therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is in triple therapy

A

LAMA+LABA+ICS ( trelegy and enerzair)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

list LAMA agent

A

tiotropium,

Aclidinium, glycopyrronium and umeclidinium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

LAMA approved for asthma

A

tiotropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

list SAMA?

A

Ipratropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which delivery methods of inhaler is best for children <5 years old

A

MDI with spacer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

role of montelukast

A

2nd line, steroid sparing and may be add on to low dose ICS in patient with concomitant rhinitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Differences in the management of asthma in young children versus adults include:

A

LTRAs and anti-allergic agents may play a greater role in children versus adults.
LABAs are not first-line adjunctive therapy in children under 5 years of age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what should we monitor for when using ICS

A

patient with history of glaucoma should have Intraocular pressure check periodically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

exercise induced bronchospasm ( EIB)

A

It is defined as a reduction in FEV1 of 15-20% after exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

is there ICS/LAMA combo

A

no, there is ICS/LABA

17
Q

which agent is safe in pregnancy

A

Short-acting inhaled beta2-adrenergic agonists, theophylline and inhaled corticosteroids (particularly budesonide) have been used extensively and are considered safe for use in pregnancy;​ however, theophylline may worsen gastroesophageal reflux, can cause nausea, and has a narrow therapeutic index, so avoid if possible. Accumulating evidence indicates montelukast may be used safely during pregnancY

18
Q

diagnosis of COPD

A

FEV1: FVC <0.7

19
Q

GOLD spirometry severity criteria

A

mild FEV1 > 80%
moderate: FEV1 50-80%
severe: 30-50%
very severe <30%

20
Q

for COPD, which only intervention can slow down FEV1 decline

A

SMOOKING CESSATION

21
Q

what does it mean when asthma is control

A

SEE pic

21
Q

what does it mean when asthma is control

A

SEE pic

22
Q

which LAMA is approved for asthma

A

tiotripium

23
Q

when is mepolizumab indicated

A

add-on therapy in adult patients with severe eosinophilic asthma who are poorly controlled on ICS plus an additional agent and who have a blood eosinophil count >150 cells/mcL

24
Q

adverse effects of montelukast

A

Headache (common), abdominal pain, flulike symptoms. Neuropsychiatric effects (e.g., depression, agitation/aggression, hallucinations, suicidal ideation)

25
Q

asthma affects which inflammatory cells and COPD?

A

Asthma: eosinophilic vs COPD=

26
Q

How to manage AECOPD

A

1: scheduled SABA+/ LAMA
2: pred 30-50mg x 5-10 days
3: add antibiotic if change in sputum purulence AND increased sputum volume or increased dyspnea

27
Q

which antibiotic for AECOPD?

A

low risk: amox, doxy, TMP/SMX, Clarithromycin, azithromycin, cefuroxime, cefprozil

HIGH risk ( >4 exacebation, chronic steroid use): amox/clav, levo or moxi

28
Q

role of Roflumilast

A

Roflumilast may be considered for add-on therapy to existing triple therapy (ICS/LAMA/LABA or LAMA + ICS/LABA) for people with COPD who have had at least 1 exacerbation in the past year

29
Q

treatment of asthma exacerbation

A

SAMA+ SABA concurrent

add steroid